Events Partner Content Real-World Evidence 2022: Rare Diseases and Innovative Thera... RWE Live convenes those involved in RWE, HTA and more.
Events Partner Content 4th Treg Directed Therapies Summit 2022 See the full potential of Treg therapies
News Japan approves Pfizer COVID vaccine for children aged 5 to 1... Japan's health ministry has authorised the use of Pfizer and BioNTech COVID-19 vaccine in children aged between five and 11.
News Biliary tract cancer drug granted orphan drug designation in... The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation.
News Covid vaccine booster raises antibody levels in fight agains... A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers.
News UK green lights Gilead Sciences, Galapagos ulcerative coliti... The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jyseleca (filgotinib) 200mg tablets to treat ulcerative colitis (UC) in adults whose UC is moderately to severely acti
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
